EQUILLIUM, INC. Increase (Decrease) in Prepaid Expense and Other Assets
EQUILLIUM, INC. (EQ) reported Increase (Decrease) in Prepaid Expense and Other Assets of $52.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$140.00K.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $192.00K.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $321.00K.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$8.00K, a 180.00% decline year-over-year.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.26M.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$2.27M, a 226.04% decline from fiscal 2023.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.80M, a 1042.41% increase from fiscal 2022.
- EQUILLIUM, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $158.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 7 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 10 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $52.00K 10-Q · filed 2026-08-13 | $373.00K derived: sum of 3 quarters · filed 2026-08-13 | $365.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $192.00K 10-Q · filed 2026-05-13 | $513.00K derived: sum of 2 quarters · filed 2026-05-13 | $505.00K derived: sum of 3 quarters · filed 2026-05-13 | -$768.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $313.00K derived: sum of 2 quarters · filed 2026-03-25 | -$960.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.26M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.28M derived: sum of 2 quarters · filed 2026-08-13 | -$1.58M 10-Q · filed 2025-11-13 | -$1.86M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.58M 10-Q · filed 2026-08-13 | -$1.85M derived: sum of 3 quarters · filed 2026-08-13 | -$1.84M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$303.00K 10-Q · filed 2026-05-13 | -$580.00K derived: sum of 2 quarters · filed 2026-05-13 | -$570.00K derived: sum of 3 quarters · filed 2026-05-13 | -$3.10M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$267.00K derived: sum of 2 quarters · filed 2026-03-25 | -$2.79M derived: sum of 3 quarters · filed 2026-03-25 | -$2.27M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.52M derived: sum of 2 quarters · filed 2025-11-13 | -$2.00M 10-Q · filed 2025-11-13 | -$1.25M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.01M 10-Q · filed 2025-08-14 | -$1.26M derived: sum of 3 quarters · filed 2025-08-14 | -$2.62M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $520.00K 10-Q · filed 2025-05-14 | $1.27M derived: sum of 2 quarters · filed 2025-05-14 | -$96.00K derived: sum of 3 quarters · filed 2025-05-14 | $342.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$616.00K derived: sum of 2 quarters · filed 2025-03-27 | -$178.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.80M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$928.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.05M 10-Q · filed 2024-11-13 | $1.66M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.42M 10-Q · filed 2024-08-08 | $3.03M derived: sum of 3 quarters · filed 2024-08-08 | $2.36M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $1.98M 10-Q · filed 2024-05-09 | $2.59M derived: sum of 2 quarters · filed 2024-05-09 | $1.92M derived: sum of 3 quarters · filed 2024-05-09 | $1.59M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$62.00K derived: sum of 2 quarters · filed 2024-03-25 | -$395.00K derived: sum of 3 quarters · filed 2024-03-25 | $158.00K 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | -$670.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.00M derived: sum of 2 quarters · filed 2023-11-08 | -$450.00K 10-Q · filed 2023-11-08 | $821.00K derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $220.00K 10-Q · filed 2023-08-09 | $1.49M derived: sum of 3 quarters · filed 2023-08-09 | $1.26M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $553.00K 10-Q · filed 2023-05-11 | $1.82M derived: sum of 2 quarters · filed 2023-05-11 | $1.59M derived: sum of 3 quarters · filed 2023-05-11 | $820.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.04M derived: sum of 2 quarters · filed 2023-03-23 | $267.00K derived: sum of 3 quarters · filed 2023-03-23 | -$214.00K 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.00M derived: sum of 2 quarters · filed 2022-11-14 | -$1.49M 10-Q · filed 2022-11-14 | -$132.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$771.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.25M 10-Q · filed 2022-08-15 | $101.00K derived: sum of 3 quarters · filed 2022-08-15 | $129.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$481.00K 10-Q · filed 2022-05-12 | $872.00K derived: sum of 2 quarters · filed 2022-05-12 | $900.00K derived: sum of 3 quarters · filed 2022-05-12 | $309.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.38M derived: sum of 2 quarters · filed 2022-03-23 | $790.00K derived: sum of 3 quarters · filed 2022-03-23 | $491.00K 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$563.00K derived: sum of 2 quarters · filed 2021-11-10 | -$862.00K 10-Q · filed 2021-11-10 | $748.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$890.00K 10-Q · filed 2021-08-10 | $720.00K derived: sum of 3 quarters · filed 2021-08-10 | $543.00K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$299.00K 10-Q · filed 2021-05-13 | $1.31M derived: sum of 2 quarters · filed 2021-05-13 | $1.13M derived: sum of 3 quarters · filed 2021-05-13 | $965.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $1.43M derived: sum of 2 quarters · filed 2021-03-24 | $1.26M derived: sum of 3 quarters · filed 2021-03-24 | $1.11M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | -$177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$346.00K derived: sum of 2 quarters · filed 2020-11-10 | -$495.00K 10-Q · filed 2020-11-10 | $613.00K derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$318.00K 10-Q · filed 2020-08-12 | $790.00K derived: sum of 3 quarters · filed 2020-08-12 | $796.00K derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | -$149.00K 10-Q · filed 2020-05-13 | $959.00K derived: sum of 2 quarters · filed 2020-05-13 | $965.00K derived: sum of 3 quarters · filed 2020-05-13 | $1.01M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $1.11M derived: sum of 2 quarters · filed 2020-03-26 | $1.16M derived: sum of 3 quarters · filed 2020-03-26 | $1.14M 10-K · filed 2020-03-26 | $1.14M 10-K · filed 2019-03-27 | |||
| 2018-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $50.00K derived: sum of 2 quarters · filed 2019-11-12 | $32.00K 10-Q · filed 2019-11-12 | $31.99K 10-Q · filed 2018-11-15 | ||||
| 2018-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $26.00K 10-Q · filed 2019-08-12 | ||||||
| 2018-03-31 | -$18.00K 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | $45.81K 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | $28.06K 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |